LobbyingUS Pharmacopeia lobbying by quarter
US Pharmacopeia's latest lobbying report covers Q2 2026, at $20K. Its first report covers Q1 2026; the issues it reports most are Foreign Relations and Health Issues.
US Pharmacopeia
- Latest quarter
- $20K
- Q2 2026 · 1 reports
- Last 12 months
- $40K
- Last 2 quarters
- vs last quarter
- 0.0%
- Q2 2026 against the quarter before
- First report
- Q1 2026
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q1 2026 | $20K | 1 |
| Q2 2026 | $20K | 1 |
Policy issues the reports name
- Foreign relations2 reports
- Health issues2 reports
A report that names several issues counts once for each.
Who was lobbied
- HOUSE OF REPRESENTATIVES2 reports
- SENATE2 reports
- State, Dept of (DOS)2 reports
Firms it paid
| Firm | ||
|---|---|---|
| Kyle House Group | $40K | 2 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| JULIAN FLEISCHMAN | Senior Legislative Assistant, Rep. Peter Meijer; Legislative Assistant, Rep. Briab Mast | Q2 2026 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/20for Q2 | Kyle House Group | $20K |
| 04/20for Q1 | Kyle House Group | $20K |
| 04/20for Q1 | Kyle House Group | Under $5,000 |